Author: Parkie

Title: Understanding Advanced Parkinson’s and Deep Brain Stimulation

Living with Parkinson’s disease (PD) brings many challenges, especially as the condition progresses into advanced stages. For those managing advanced PD, finding effective treatment options is critical to improving quality of life. One promising option for advanced PD patients is Deep Brain Stimulation (DBS), a surgical procedure that has been proven to alleviate many of… Continue reading Title: Understanding Advanced Parkinson’s and Deep Brain Stimulation

Gut Health and Parkinson’s Risk

The Crucial Link Between Mucosal Damage and Parkinson’s Disease Recent research has identified a significant connection between mucosal damage in the gastrointestinal (GI) tract and an increased risk of developing Parkinson’s disease (PD). Mucosal damage, which involves erosion, breaks, or sores in the mucous lining of the GI tract, was associated with a 76 percent… Continue reading Gut Health and Parkinson’s Risk

Semaglutide: A Dual Diabetes and Alzheimer’s Aid

Semaglutide medications, commonly known under brand names like Ozempic and Wegovy, represent a significant advancement in the management of type 2 diabetes and have potential implications for Alzheimer’s disease prevention. These medications work by enhancing the body’s insulin response and curbing appetite, thus aiding in weight management and metabolic health—factors critical in the pathology of… Continue reading Semaglutide: A Dual Diabetes and Alzheimer’s Aid

Understanding Alexithymia in Parkinson’s Disease

Alexithymia, a non-motor symptom of Parkinson’s disease (PD), presents significant challenges by impairing the ability to recognize and express emotions. This condition affects a considerable number of individuals with PD, influencing their emotional and cognitive well-being. Understanding and managing this symptom is crucial for improving the quality of life in PD patients. Alexithymia in Parkinson’s… Continue reading Understanding Alexithymia in Parkinson’s Disease